» Articles » PMID: 36453307

Efficacy and Safety of Ultrasound Cycloplasty in Indian Eyes with Open-angle Glaucoma

Overview
Specialty Ophthalmology
Date 2022 Dec 1
PMID 36453307
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the safety and efficacy of ultrasound cycloplasty in eyes with primary or secondary open-angle glaucoma, not amenable to adequate control of intra-ocular pressure (IOP) with medical treatment.

Methods: Prospective interventional cohort study of 28 eyes of 28 subjects in a tertiary eye care centre in India in patients with open-angle glaucoma. All enrolled eyes underwent ultrasound cycloplasty with the second-generation probe with six shots of 8 s each, operated by a single surgeon between November 2018 and January 2020. They were followed up for a period of 12 months. The primary treatment outcome was IOP and the secondary outcomes were vision and postoperative complications.

Results: A total of 28 eyes of 28 patients were studied, and the mean age was 63.82 ± 6.46 years. Primary open-angle glaucoma (75%) was the most common etiology. There was significant reduction in IOP from the baseline (24.93 ± 4.27 mmHg) to the postoperative value (15.82 ± 3.14 mmHg) at the end of 12 months (P < 0.00001). Mean reduction in IOP was 9.14 ± 4.09 mmHg at 12 months (36.66%). Number of ocular hypotensives reduced significantly from baseline (3.32 ± 0.47) to 12-month postoperative follow-up (0.68 ± 0.74) (P < 0.00001). Qualified success was achieved in 89.28% eyes. No major complications were noted.

Conclusion: Ultrasound cycloplasty is found to be effective and safe in eyes with open-angle glaucoma because of the primary or secondary etiology, being more effective in the former.

Citing Articles

Efficacy and safety of ultrasound cycloplasty for the treatment of glaucoma: a Meta-analysis.

Wu T, Yin X, Li J, Lu P Int J Ophthalmol. 2023; 16(8):1317-1325.

PMID: 37602344 PMC: 10398525. DOI: 10.18240/ijo.2023.08.19.


Commentary: High-intensity focused ultrasound - A panacea in the making?.

Behera G, Kaliaperumal S Indian J Ophthalmol. 2022; 70(12):4172-4173.

PMID: 36453308 PMC: 9940530. DOI: 10.4103/ijo.IJO_2037_22.

References
1.
Mastropasqua R, Fasanella V, Mastropasqua A, Ciancaglini M, Agnifili L . High-Intensity Focused Ultrasound Circular Cyclocoagulation in Glaucoma: A Step Forward for Cyclodestruction?. J Ophthalmol. 2017; 2017:7136275. PMC: 5420440. DOI: 10.1155/2017/7136275. View

2.
Mastropasqua R, Agnifili L, Fasanella V, Toto L, Brescia L, Silvio Di Staso . Uveo-scleral outflow pathways after ultrasonic cyclocoagulation in refractory glaucoma: an anterior segment optical coherence tomography and in vivo confocal study. Br J Ophthalmol. 2016; 100(12):1668-1675. DOI: 10.1136/bjophthalmol-2015-308069. View

3.
Aptel F, Denis P, Rouland J, Renard J, Bron A . Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery. Acta Ophthalmol. 2015; 94(5):e268-77. DOI: 10.1111/aos.12913. View

4.
Deb-Joardar N, Reddy K . Application of high intensity focused ultrasound for treatment of open-angle glaucoma in Indian patients. Indian J Ophthalmol. 2018; 66(4):517-523. PMC: 5892053. DOI: 10.4103/ijo.IJO_1024_17. View

5.
Marques R, Ferreira N, Sousa D, Barata A, Sens P, Marques-Neves C . High intensity focused ultrasound for glaucoma: 1-year results from a prospective pragmatic study. Eye (Lond). 2020; 35(2):484-489. PMC: 8027663. DOI: 10.1038/s41433-020-0878-0. View